Tapewire

Nasdaq · USD

BMRN

BIOMARIN PHARMACEUTICAL INC

Export transactions ↓
Tapewire entity
2404
SEC CIK
0001048477
Parsed reports
685

Last 12 months

Inside the activity.

0 purchase rows · 5 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202602
Mar 202601
Apr 202600
May 202601
Jun 202600
Jul 202600
Aug 202600
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 15, 2017 Filed Mar 17, 2017 22:27 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Tax withholdingCommon Stock 15,690 $92.50 $1,451,325.00
Disclosure

SEC source: 0001140361-17-012641 · doc1.xml · nonDerivative · entry 3

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 190,674

Read SEC document
March 15, 2017 Filed Mar 17, 2017 22:27 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 5,000 $91.42 $457,100.00
Disclosure

SEC source: 0001140361-17-012641 · doc1.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 206,364

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 15, 2016.

F2 · price: All shares were sold at the same price.

Read SEC document
March 15, 2017 Filed Mar 17, 2017 22:27 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 5,000 $17.33 $86,650.00
Disclosure

SEC source: 0001140361-17-012641 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 211,364

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 15, 2016.

Read SEC document
March 13, 2017 Filed Mar 15, 2017 23:16 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 5,000 $0.00 Strike: $17.33 $0.00
Disclosure

SEC source: 0001140361-17-012180 · doc1.xml · derivative · entry 4

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,423

Underlying: Common Stock · 5,000 shares

Expires 2017-06-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 15, 2016.

F3 · balance_after: Reflects the number of stock options outstanding after the transaction from this specific stock option grant.

Read SEC document
March 13, 2017 Filed Mar 15, 2017 23:16 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 5,000 $92.68 $463,400.00
Disclosure

SEC source: 0001140361-17-012180 · doc1.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 206,364

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 15, 2016.

F2 · price: All shares were sold at the same price.

Read SEC document
March 13, 2017 Filed Mar 15, 2017 23:16 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 5,000 $17.33 $86,650.00
Disclosure

SEC source: 0001140361-17-012180 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 211,364

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 15, 2016.

Read SEC document
March 10, 2017 Filed Mar 13, 2017 23:59 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 5,000 $0.00 Strike: $17.33 $0.00
Disclosure

SEC source: 0001140361-17-011816 · doc1.xml · derivative · entry 7

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,423

Underlying: Common Stock · 5,000 shares

Expires 2017-06-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 15, 2016.

F3 · balance_after: Reflects the number of stock options outstanding after the transaction from this specific stock option grant.

Read SEC document
March 10, 2017 Filed Mar 13, 2017 23:59 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 5,000 $91.09 $455,450.00
Disclosure

SEC source: 0001140361-17-011816 · doc1.xml · nonDerivative · entry 4

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 206,364

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 15, 2016.

F2 · price: All shares were sold at the same price.

Read SEC document
March 10, 2017 Filed Mar 13, 2017 23:59 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 5,000 $17.33 $86,650.00
Disclosure

SEC source: 0001140361-17-011816 · doc1.xml · nonDerivative · entry 3

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 211,364

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 15, 2016.

F2 · price: All shares were sold at the same price.

Read SEC document
March 09, 2017 Filed Mar 13, 2017 23:59 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 6,000 $0.00 Strike: $17.33 $0.00
Disclosure

SEC source: 0001140361-17-011816 · doc1.xml · derivative · entry 6

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,423

Underlying: Common Stock · 60,000 shares

Expires 2017-06-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 15, 2016.

F3 · balance_after: Reflects the number of stock options outstanding after the transaction from this specific stock option grant.

Read SEC document
March 09, 2017 Filed Mar 13, 2017 23:59 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 6,000 $90.18 $541,080.00
Disclosure

SEC source: 0001140361-17-011816 · doc1.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 206,364

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 15, 2016.

F2 · price: All shares were sold at the same price.

Read SEC document
March 09, 2017 Filed Mar 13, 2017 23:59 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 6,000 $17.33 $103,980.00
Disclosure

SEC source: 0001140361-17-011816 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 212,364

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 15, 2016.

Read SEC document
March 07, 2017 Filed Mar 9, 2017 00:31 UTC
Ajer Jeffrey RobertEVP, Chief Commercial Officer
SaleCommon Stock 5,000 $90.56 $452,800.00
Disclosure

SEC source: 0001140361-17-011081 · doc1.xml · nonDerivative · entry 1

Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,510

F1 · date: Trade made pursuant to a 10b5-1 plan executed on August 18, 2016.

F2 · price: All shares were sold at the same price.

Read SEC document
March 06, 2017 Filed Mar 9, 2017 00:28 UTC
SPIEGELMAN DANIEL KEVP, Chief Financial Officer
SaleCommon Stock 2,303 $93.32 $214,915.96
Disclosure

SEC source: 0001140361-17-011079 · doc1.xml · nonDerivative · entry 1

SPIEGELMAN DANIEL K · CIK 0001238403 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,761

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 16, 2016.

F2 · price: All shares were sold at the same price.

Read SEC document
March 06, 2017 Filed Mar 9, 2017 00:24 UTC
Davis George EricEVP, General Counsel
SaleCommon Stock 1,498 $93.32 $139,793.36
Disclosure

SEC source: 0001140361-17-011077 · doc1.xml · nonDerivative · entry 1

Davis George Eric · CIK 0001380710 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,962

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 2, 2016.

F2 · price: All shares were sold at the same price.

Read SEC document
March 03, 2017 Filed Mar 7, 2017 23:42 UTC
BAFFI ROBERTEVP, Technical Operations
Tax withholdingCommon Stock 1,749 $93.95 $164,318.55
Disclosure

SEC source: 0001140361-17-010940 · doc1.xml · nonDerivative · entry 1

BAFFI ROBERT · CIK 0001274826 · EVP, Technical Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 138,910

Read SEC document
March 03, 2017 Filed Mar 7, 2017 23:44 UTC
Ajer Jeffrey RobertEVP, Chief Commercial Officer
Tax withholdingCommon Stock 1,749 $93.95 $164,318.55
Disclosure

SEC source: 0001140361-17-010942 · doc1.xml · nonDerivative · entry 1

Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,510

Read SEC document
March 03, 2017 Filed Mar 7, 2017 23:34 UTC
FUCHS HENRY JPresident, Worldwide R&D
Tax withholdingCommon Stock 2,924 $93.95 $274,709.80
Disclosure

SEC source: 0001140361-17-010930 · doc1.xml · nonDerivative · entry 1

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,518

Read SEC document
March 03, 2017 Filed Mar 7, 2017 23:37 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Tax withholdingCommon Stock 8,989 $93.95 $844,516.55
Disclosure

SEC source: 0001140361-17-010933 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 206,364

Read SEC document
March 03, 2017 Filed Mar 7, 2017 23:40 UTC
Davis George EricEVP, General Counsel
Tax withholdingCommon Stock 1,596 $93.95 $149,944.20
Disclosure

SEC source: 0001140361-17-010937 · doc1.xml · nonDerivative · entry 1

Davis George Eric · CIK 0001380710 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,460

Read SEC document
March 03, 2017 Filed Mar 7, 2017 23:38 UTC
SPIEGELMAN DANIEL KEVP, Chief Financial Officer
Tax withholdingCommon Stock 2,283 $93.95 $214,487.85
Disclosure

SEC source: 0001140361-17-010935 · doc1.xml · nonDerivative · entry 1

SPIEGELMAN DANIEL K · CIK 0001238403 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,064

Read SEC document
March 01, 2017 Filed Mar 2, 2017 23:20 UTC
SPIEGELMAN DANIEL KEVP, Chief Financial Officer
SaleCommon Stock 5,000 $94.50 $472,500.00
Disclosure

SEC source: 0001140361-17-010370 · doc1.xml · nonDerivative · entry 3

SPIEGELMAN DANIEL K · CIK 0001238403 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,347

F1 · date: Transaction made pursuant to a 10b5-1 trading plan executed on November 16, 2016.

F2 · price: All shares were sold at the same price.

Read SEC document
March 01, 2017 Filed Mar 2, 2017 23:14 UTC Exercise / conversionStock Option (Right to buy) Common Stock · Derivative 7,500 $0.00 Strike: $17.33 $0.00
Disclosure

SEC source: 0001140361-17-010367 · doc1.xml · derivative · entry 3

LAWLIS V BRYAN · CIK 0001247681 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,500 shares

Expires 2017-06-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Transaction made pursuant to a 10b5-1 trading plan executed on June 6, 2016.

F3 · derivative.exercise_date: Original option grant vests 6/48ths on December 7, 2007, and 1/48th on the 7th day of every month thereafter

F4 · balance_after: Reflects the number of stock options that remain outstanding from this specific stock grant following the reported transaction.

Read SEC document
March 01, 2017 Filed Mar 2, 2017 23:14 UTC SaleCommon Stock 7,500 $95.00 $712,500.00
Disclosure

SEC source: 0001140361-17-010367 · doc1.xml · nonDerivative · entry 2

LAWLIS V BRYAN · CIK 0001247681 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,860

F1 · date: Transaction made pursuant to a 10b5-1 trading plan executed on June 6, 2016.

F2 · price: All shares were sold at the same price.

Read SEC document
March 01, 2017 Filed Mar 2, 2017 23:14 UTC Exercise / conversionCommon Stock 7,500 $17.33 $129,975.00
Disclosure

SEC source: 0001140361-17-010367 · doc1.xml · nonDerivative · entry 1

LAWLIS V BRYAN · CIK 0001247681 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,360

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · date: All shares were sold at the same price.

Read SEC document
February 28, 2017 Filed Mar 2, 2017 23:20 UTC
SPIEGELMAN DANIEL KEVP, Chief Financial Officer
Exercise / conversionStock Option (right to buy) Common Stock · Derivative 30,000 $0.00 Strike: $63.10 $0.00
Disclosure

SEC source: 0001140361-17-010370 · doc1.xml · derivative · entry 4

SPIEGELMAN DANIEL K · CIK 0001238403 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,700

Underlying: Common Stock · 30,000 shares

Expires 2024-06-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Transaction made pursuant to a 10b5-1 trading plan executed on November 16, 2016.

F3 · derivative.exercise_date: Original option grant vests 6/48ths on December 4, 2014, and 1/48th on the 4th day of every month thereafter.

F4 · balance_after: Reflects the number of stock options that remain outstanding from this specific stock grant following the reported transaction.

Read SEC document
February 28, 2017 Filed Mar 2, 2017 23:20 UTC
SPIEGELMAN DANIEL KEVP, Chief Financial Officer
SaleCommon Stock 30,000 $94.00 $2,820,000.00
Disclosure

SEC source: 0001140361-17-010370 · doc1.xml · nonDerivative · entry 2

SPIEGELMAN DANIEL K · CIK 0001238403 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,347

F1 · date: Transaction made pursuant to a 10b5-1 trading plan executed on November 16, 2016.

F2 · price: All shares were sold at the same price.

Read SEC document
February 28, 2017 Filed Mar 2, 2017 23:20 UTC
SPIEGELMAN DANIEL KEVP, Chief Financial Officer
Exercise / conversionCommon Stock 30,000 $63.10 $1,893,000.00
Disclosure

SEC source: 0001140361-17-010370 · doc1.xml · nonDerivative · entry 1

SPIEGELMAN DANIEL K · CIK 0001238403 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,347

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Transaction made pursuant to a 10b5-1 trading plan executed on November 16, 2016.

Read SEC document
February 24, 2017 Filed Feb 28, 2017 21:51 UTC
SPIEGELMAN DANIEL KEVP, Chief Financial Officer
GrantCommon Stock 12,247 $0.00 $0.00
Disclosure

SEC source: 0001140361-17-009697 · doc1.xml · nonDerivative · entry 1

SPIEGELMAN DANIEL K · CIK 0001238403 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,347

F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee Chair certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis.

F2 · shares: Represents the total number of RSUs earned pursuant to a calculation based on the level of the Issuer's total adjusted revenues for the fiscal year ended December 31, 2016, as certified by its audited financials, set forth in the performance-based RSU awards previously granted under the Issuer's 2006 Share Incentive Plan.

F3 · shares: Although earned, the RSUs only vest according to the following schedule: 1/3 vests on each of March 15, 2017, 2018 and 2019, so long as the reporting person remains continuously employed with the Issuer through that date, subject to earlier vesting upon certain corporate events.

Read SEC document
February 24, 2017 Filed Feb 28, 2017 21:48 UTC
Davis George EricEVP, General Counsel
GrantCommon Stock 11,258 $0.00 $0.00
Disclosure

SEC source: 0001140361-17-009691 · doc1.xml · nonDerivative · entry 1

Davis George Eric · CIK 0001380710 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,056

F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee Chair certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis.

F2 · shares: Represents the total number of RSUs earned pursuant to a calculation based on the level of the Issuer's total adjusted revenues for the fiscal year ended December 31, 2016, as certified by its audited financials, set forth in the performance-based RSU awards previously granted under the Issuer's 2006 Share Incentive Plan.

F3 · shares: Although earned, the RSUs only vest according to the following schedule: 1/3 vests on each of March 15, 2017, 2018 and 2019, so long as the reporting person remains continuously employed with the Issuer through that date, subject to earlier vesting upon certain corporate events.

Read SEC document
February 24, 2017 Filed Feb 28, 2017 21:45 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
GrantCommon Stock 44,671 $0.00 $0.00
Disclosure

SEC source: 0001140361-17-009683 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 215,353

F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee Chair certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis.

F3 · shares: Although earned, the RSUs only vest according to the following schedule: 1/3 vests on each of March 15, 2017, 2018 and 2019, so long as the reporting person remains continuously employed with the Issuer through that date, subject to earlier vesting upon certain corporate events.

F2 · shares: Represents the total number of RSUs earned pursuant to a calculation based on the level of the Issuer's total adjusted revenues for the fiscal year ended December 31, 2016, as certified by its audited financials, set forth in the performance-based RSU awards previously granted under the Issuer's 2006 Share Incentive Plan.

Read SEC document
February 24, 2017 Filed Feb 28, 2017 21:42 UTC
BAFFI ROBERTEVP, Technical Operations
GrantCommon Stock 11,917 $0.00 $0.00
Disclosure

SEC source: 0001140361-17-009678 · doc1.xml · nonDerivative · entry 1

BAFFI ROBERT · CIK 0001274826 · EVP, Technical Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,659

F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee Chair certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis.

F2 · shares: Represents the total number of RSUs earned pursuant to a calculation based on the level of the Issuer's total adjusted revenues for the fiscal year ended December 31, 2016, as certified by its audited financials, set forth in the performance-based RSU awards previously granted under the Issuer's 2006 Share Incentive Plan.

F3 · shares: Although earned, the RSUs only vest according to the following schedule: 1/3 vests on each of March 15, 2017, 2018 and 2019, so long as the reporting person remains continuously employed with the Issuer through that date, subject to earlier vesting upon certain corporate events.

Read SEC document
February 24, 2017 Filed Feb 28, 2017 21:39 UTC
Ajer Jeffrey RobertEVP, Chief Commercial Officer
GrantCommon Stock 11,917 $95.61 $1,139,396.29
Disclosure

SEC source: 0001140361-17-009672 · doc1.xml · nonDerivative · entry 1

Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,259

F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee Chair certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis.

F2 · price: Represents the total number of RSUs earned pursuant to a calculation based on the level of the Issuer's total adjusted revenues for the fiscal year ended December 31, 2016, as certified by its audited financials, set forth in the performance-based RSU awards previously granted under the Issuer's 2006 Share Incentive Plan.

F3 · price: Although earned, the RSUs only vest according to the following schedule: 1/3 vests on each of March 15, 2017, 2018 and 2019, so long as the reporting person remains continuously employed with the Issuer through that date, subject to earlier vesting upon certain corporate events.

Read SEC document
February 24, 2017 Filed Feb 28, 2017 21:37 UTC
FUCHS HENRY JPresident, Worldwide R&D
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 15,000 $0.00 Strike: $26.49 $0.00
Disclosure

SEC source: 0001140361-17-009668 · doc1.xml · derivative · entry 4

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,225

Underlying: Common Stock · 15,000 shares

Expires 2021-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · date: Trade made pursuant to a 10b5-1 plan executed on May 12, 2016.

F6 · balance_after: Reflects the number of stock options outstanding after the transaction from this specific stock option grant.

Read SEC document
February 24, 2017 Filed Feb 28, 2017 21:37 UTC
FUCHS HENRY JPresident, Worldwide R&D
SaleCommon Stock 15,000 $87.99 $1,319,850.00
Disclosure

SEC source: 0001140361-17-009668 · doc1.xml · nonDerivative · entry 3

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 128,442

F4 · date: Trade made pursuant to a 10b5-1 plan executed on May 12, 2016.

F5 · price: All shares were sold at the same price.

Read SEC document
February 24, 2017 Filed Feb 28, 2017 21:37 UTC
FUCHS HENRY JPresident, Worldwide R&D
Exercise / conversionCommon Stock 15,000 $26.49 $397,350.00
Disclosure

SEC source: 0001140361-17-009668 · doc1.xml · nonDerivative · entry 2

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 143,442

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · date: Trade made pursuant to a 10b5-1 plan executed on May 12, 2016.

Read SEC document
February 24, 2017 Filed Feb 28, 2017 21:37 UTC
FUCHS HENRY JPresident, Worldwide R&D
GrantCommon Stock 14,564 $0.00 $0.00
Disclosure

SEC source: 0001140361-17-009668 · doc1.xml · nonDerivative · entry 1

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 128,442

F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee Chair certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis.

F3 · shares: Although earned, the RSUs only vest according to the following schedule: 1/3 vests on each of March 15, 2017, 2018 and 2019, so long as the reporting person remains continuously employed with the Issuer through that date, subject to earlier vesting upon certain corporate events.

F2 · shares: Represents the total number of RSUs earned pursuant to a calculation based on the level of the Issuer's total adjusted revenues for the fiscal year ended December 31, 2016, as certified by its audited financials, set forth in the performance-based RSU awards previously granted under the Issuer's 2006 Share Incentive Plan.

Read SEC document
January 26, 2017 Filed Jan 27, 2017 22:46 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (right to buy Common Stock) · Derivative 5,000 $0.00 Strike: $17.33 $0.00
Disclosure

SEC source: 0001140361-17-003260 · doc1.xml · derivative · entry 7

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,423

Underlying: Common Stock · 5,000 shares

Expires 2017-06-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 15, 2016.

F3 · balance_after: Reflects the number of stock options outstanding after the transaction from this specific stock option grant.

Read SEC document
January 26, 2017 Filed Jan 27, 2017 22:46 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 5,000 $84.00 $420,000.00
Disclosure

SEC source: 0001140361-17-003260 · doc1.xml · nonDerivative · entry 4

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 170,682

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 15, 2016.

F2 · price: All shares were sold at the same price.

Read SEC document
January 26, 2017 Filed Jan 27, 2017 22:46 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 5,000 $17.33 $86,650.00
Disclosure

SEC source: 0001140361-17-003260 · doc1.xml · nonDerivative · entry 3

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 175,682

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 15, 2016.

Read SEC document
January 25, 2017 Filed Jan 27, 2017 22:46 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (right to buy Common Stock) · Derivative 5,000 $0.00 Strike: $17.33 $0.00
Disclosure

SEC source: 0001140361-17-003260 · doc1.xml · derivative · entry 6

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,423

Underlying: Common Stock · 5,000 shares

Expires 2017-06-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 15, 2016.

F3 · balance_after: Reflects the number of stock options outstanding after the transaction from this specific stock option grant.

Read SEC document
January 25, 2017 Filed Jan 27, 2017 22:46 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 5,000 $84.44 $422,200.00
Disclosure

SEC source: 0001140361-17-003260 · doc1.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 170,682

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 15, 2016.

F2 · price: All shares were sold at the same price.

Read SEC document
January 25, 2017 Filed Jan 27, 2017 22:46 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 5,000 $17.33 $86,650.00
Disclosure

SEC source: 0001140361-17-003260 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 175,682

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 15, 2016.

Read SEC document
January 11, 2017 Filed Jan 12, 2017 23:48 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (right to buy Common Stock) · Derivative 4,000 $0.00 Strike: $17.33 $0.00
Disclosure

SEC source: 0001140361-17-001750 · doc1.xml · derivative · entry 7

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,423

Underlying: Common Stock · 4,000 shares

Expires 2017-06-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 15, 2016.

F3 · balance_after: Reflects the number of stock options outstanding after the transaction from this specific stock option grant.

Read SEC document
January 11, 2017 Filed Jan 12, 2017 23:48 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 4,000 $89.84 $359,360.00
Disclosure

SEC source: 0001140361-17-001750 · doc1.xml · nonDerivative · entry 4

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 170,682

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 15, 2016.

F2 · price: All shares were sold at the same price.

Read SEC document
January 11, 2017 Filed Jan 12, 2017 23:48 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 4,000 $17.33 $69,320.00
Disclosure

SEC source: 0001140361-17-001750 · doc1.xml · nonDerivative · entry 3

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 174,682

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 15, 2016.

Read SEC document
January 10, 2017 Filed Jan 12, 2017 23:48 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (right to buy Common Stock) · Derivative 4,000 $0.00 Strike: $17.33 $0.00
Disclosure

SEC source: 0001140361-17-001750 · doc1.xml · derivative · entry 6

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 97,423

Underlying: Common Stock · 4,000 shares

Expires 2017-06-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 15, 2016.

F3 · balance_after: Reflects the number of stock options outstanding after the transaction from this specific stock option grant.

Read SEC document
January 10, 2017 Filed Jan 12, 2017 23:48 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 4,000 $91.31 $365,240.00
Disclosure

SEC source: 0001140361-17-001750 · doc1.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 170,682

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 15, 2016.

F2 · price: All shares were sold at the same price.

Read SEC document
January 10, 2017 Filed Jan 12, 2017 23:48 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 4,000 $17.33 $69,320.00
Disclosure

SEC source: 0001140361-17-001750 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 174,682

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 15, 2016.

Read SEC document
January 09, 2017 Filed Jan 10, 2017 21:50 UTC
SPIEGELMAN DANIEL KEVP, Chief Financial Officer
SaleCommon Stock 5,000 $90.00 $450,000.00
Disclosure

SEC source: 0001140361-17-001375 · doc1.xml · nonDerivative · entry 1

SPIEGELMAN DANIEL K · CIK 0001238403 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,100

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 16, 2016.

F2 · price: All shares were sold at the same price.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.